Virax Gross Profit vs Minority Interest Analysis
| VRAX Stock | USD 1.94 0.06 3.19% |
Virax Biolabs financial indicator trend analysis is much more than just breaking down Virax Biolabs Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Virax Biolabs Group is a good investment. Please check the relationship between Virax Biolabs Gross Profit and its Minority Interest accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virax Biolabs Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Gross Profit vs Minority Interest
Gross Profit vs Minority Interest Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Virax Biolabs Group Gross Profit account and Minority Interest. At this time, the significance of the direction appears to have no relationship.
The correlation between Virax Biolabs' Gross Profit and Minority Interest is 0.08. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Minority Interest in the same time period over historical financial statements of Virax Biolabs Group, assuming nothing else is changed. The correlation between historical values of Virax Biolabs' Gross Profit and Minority Interest is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Virax Biolabs Group are associated (or correlated) with its Minority Interest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Minority Interest has no effect on the direction of Gross Profit i.e., Virax Biolabs' Gross Profit and Minority Interest go up and down completely randomly.
Correlation Coefficient | 0.08 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Virax Biolabs Group minus its cost of goods sold. It is profit before Virax Biolabs operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Virax Biolabs Group whose combined shares represent less than 50% of the total outstanding shares issued by Virax Biolabs have a minority interest in Virax Biolabs.Most indicators from Virax Biolabs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Virax Biolabs Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virax Biolabs Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Virax Biolabs' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 0.30 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.7 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 15.4K | 15.5K | 26.9K | 28.3K | Depreciation And Amortization | 1.7M | 1.0 | 103.1K | 97.9K |
Virax Biolabs fundamental ratios Correlations
Click cells to compare fundamentals
Virax Biolabs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.